NBIX
NBIX
NASDAQ · Biotechnology

Neurocrine Biosciences Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$152.25
+2.66 (+1.78%)
Analyst Consensus
Strong Buy
35
Analysts
Very High
Coverage
Buy 30 86%
Hold 5 14%
Sell 0 0%
Price Target
Analyst Price Target -16.6% upside
Low Target $104.30
Average Target $126.93
High Target $177.55
Current Price $152.25
Current
$152.25
Target
$126.93
$104.30 $126.93 avg $177.55
Scenario Analysis
Bear Case
$104.30
-31.5%
Low target
Base Case
$126.93
-16.6%
Avg target
Bull Case
$177.55
+16.6%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$160.18
-5.0% from high
52-Week Low
$115.66
+31.6% from low
50-Day SMA
$139.44
+9.2% vs SMA
200-Day SMA
$135.94
+12.0% vs SMA
RSI (14)
38.6
Neutral
Target vs 52W High
$126.93
-20.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%